Colorectal Cancer
Cancers of the colon and the rectum are the fourth-most commonly diagnosed cancers in the U.S. Because of their similarities, they are merged into a single category known as colorectal cancer. Although this disease is the second-leading cause of cancer death, thanks to more rigorous screening and regular treatment advances, the percentage of deaths from colorectal cancer continues to drop. In addition to treating colorectal cancers, our team offers care for many noncancerous colorectal conditions.
Nearly 151,000 people will get colorectal cancer in the United States each year. About 1 in 21 men and 1 in 23 women will get the disease during their lifetimes. Colorectal cancer is the third leading cause of cancer death in women and the second leading cause of cancer death in men. However, the colorectal cancer survival rate has been climbing steadily over the last few decades.
Without symptoms, polyps containing cancer cells can stay lodged in the colon wall for years. Therefore, screening increases the chances of catching colorectal cancer early, before it has spread and when it is more likely to be cured. At City of Hope, we offer three types of screenings to detect colorectal cancer: colonoscopy, stool DNA testing and genetic screening.
City of Hope’s approach to treating colorectal cancer focuses on precision medicine. That means we apply precise and minimally invasive surgical techniques and test individual cancer cells to find drug combinations that would work best for your specific cancer.
Colorectal cancer is a highly complex disease that can act in many different ways in the body. Clinical trials at City of Hope focus on those differences — and designing therapies that affect how colorectal cancer develops, progresses and spreads.
Getting treated for colorectal cancer at City of Hope means you are steps away from labs where our researchers develop new treatments every day.
When you come to City of Hope, you automatically gain access to an unparalleled array of support services to help you and your loved ones take each step during and after your colorectal cancer treatment.
Our Expertise
With superior survival outcomes in the Greater Los Angeles region for all stages, City of Hope’s aptitude for treating colorectal cancer stands on its own.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
